JP2011519030A - ヒトおよび動物における生物学的老化、再生能、発癌リスク、加齢性疾患を発症するリスクおよび慢性疾患の予後を測定するための、ｄｎａ損傷およびテロメア機能不全を測定するためのマーカー - Google Patents

ヒトおよび動物における生物学的老化、再生能、発癌リスク、加齢性疾患を発症するリスクおよび慢性疾患の予後を測定するための、ｄｎａ損傷およびテロメア機能不全を測定するためのマーカー Download PDF

Info

Publication number
JP2011519030A
JP2011519030A JP2011505533A JP2011505533A JP2011519030A JP 2011519030 A JP2011519030 A JP 2011519030A JP 2011505533 A JP2011505533 A JP 2011505533A JP 2011505533 A JP2011505533 A JP 2011505533A JP 2011519030 A JP2011519030 A JP 2011519030A
Authority
JP
Japan
Prior art keywords
protein
risk
measuring
activity
age
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2011505533A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011519030A5 (enExample
Inventor
ルドルフ、レンハルト
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of JP2011519030A publication Critical patent/JP2011519030A/ja
Publication of JP2011519030A5 publication Critical patent/JP2011519030A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
JP2011505533A 2008-04-25 2009-04-27 ヒトおよび動物における生物学的老化、再生能、発癌リスク、加齢性疾患を発症するリスクおよび慢性疾患の予後を測定するための、ｄｎａ損傷およびテロメア機能不全を測定するためのマーカー Pending JP2011519030A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08155176.4 2008-04-25
EP08155176 2008-04-25
PCT/EP2009/055059 WO2009130330A1 (de) 2008-04-25 2009-04-27 Marker zur bestimmung der biologischen alterung

Publications (2)

Publication Number Publication Date
JP2011519030A true JP2011519030A (ja) 2011-06-30
JP2011519030A5 JP2011519030A5 (enExample) 2012-07-26

Family

ID=39651415

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011505533A Pending JP2011519030A (ja) 2008-04-25 2009-04-27 ヒトおよび動物における生物学的老化、再生能、発癌リスク、加齢性疾患を発症するリスクおよび慢性疾患の予後を測定するための、ｄｎａ損傷およびテロメア機能不全を測定するためのマーカー

Country Status (4)

Country Link
US (1) US20110104698A1 (enExample)
EP (1) EP2281202A1 (enExample)
JP (1) JP2011519030A (enExample)
WO (1) WO2009130330A1 (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021256346A1 (ja) * 2020-06-16 2021-12-23 ファナック株式会社 ツール設定管理機能を備えた制御装置、制御システム、及びツール
JP2023099826A (ja) * 2013-03-15 2023-07-13 エリクサージェン セラピューティクス，インコーポレイティド ヒト細胞を若返らせるためのｚｓｃａｎ４の使用方法

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20200386771A1 (en) * 2017-11-14 2020-12-10 Hiroshima University Aging condition evaluation method, information presentation method, and screening method for substance that improves or prevents aging condition
EP3674418A1 (en) * 2018-12-26 2020-07-01 Life Length S.L. Method for measuring telomere associated variables and uses thereof for the diagnosis and/or prognosis of telomeric-associated diseases
CN111333713B (zh) * 2020-03-27 2021-06-25 江南大学 一种表达抗菌肽基因的植物乳杆菌
CN111398456A (zh) * 2020-03-31 2020-07-10 中国科学院昆明动物研究所 指征健康老龄关键通路的内源性代谢小分子标志物及应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5358850A (en) * 1992-06-19 1994-10-25 Shionogi Seiyaku Kabushiki Kaisha Sandwich immunoassay of β-n-acetylglucosaminidase and monoclonal antibody used therein
JPH08319298A (ja) * 1995-05-25 1996-12-03 Fujirebio Inc 抗ヒト老化マーカータンパク質モノクローナル抗体及びそれを用いる測定方法
JP3754611B2 (ja) * 2000-10-03 2006-03-15 旭テクノグラス株式会社 ヒト老化マーカー及びストレスマーカーの検定方法
US20020192679A1 (en) * 2001-02-21 2002-12-19 Susanna Chubinskaya Methods of using bone morphogenic proteins as biomarkers for determining cartilage degeneration and aging
CA2441086A1 (en) * 2001-03-19 2002-09-26 Wisconsin Alumni Research Foundation Identification of gene expression alterations underlying the aging process in mammals
US20060099586A1 (en) * 2002-06-07 2006-05-11 Lee Jonathan M Eef1a2 for use in the prognosis, diagnosis, and treatment of cancer
US7588895B2 (en) * 2006-01-11 2009-09-15 The Regents Of The University Of California Biomarkers for oral tongue cancer metastasis and extracapsular spread (ECS)

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JPN6012057949; Ｎ．　ＧＩＡＮＮＥＴＴＩ: 'ＡＣＣＵＭＵＬＡＴＩＯＮ　ＯＦ　Ｙｍ１／２　ＰＲＯＴＥＩＮ　ＩＮ　ＴＨＥ　ＭＯＵＳＥ　ＯＬＦＡＣＴＯＲＹ　ＥＰＩＴＨＥＬＩＵＭ　ＤＵＲＩＮＧ　ＲＥＧＥＮＥＲＡＴＩＯＮ　ＡＮＤ　ＡＧＩＮＧ' Ｎｅｕｒｏｓｃｉｅｎｃｅ Ｖｏｌ．１２３／Ｉｓｓ．４, 2004, ９０７-９１７ *
JPN6013027463; Ｍｅｈｍｅｔ　Ａｇｉｒｂａｓｌｉ: 'Ｕｒｉｎａｒｙ　Ｎ-Ａｃｅｔｙｌ-ｂｅｔａ-Ｄ-Ｇｌｕｃｏｓａｍｉｎｉｄａｓｅ　Ｃｈａｎｇｅｓ　ｉｎ　Ｒｅｌａｔｉｏｎ　ｔｏ　Ａｇｅ，　Ｓｅｘ，　Ｒａｃｅ，　ａｎｄ　Ｄｉａｓｔｏｌｉｃ　ａｎｄ　Ｓｙｓ' ｔｈｅ　Ａｍｅｒｉｃａｎ　Ｊｏｕｒｎａｌ　ｏｆ　Ｈｙｐｅｒｔｅｎｓｉｏｎ Ｖｏｌ．９／Ｎｏ．２, 199602, １５７-１６１ *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023099826A (ja) * 2013-03-15 2023-07-13 エリクサージェン セラピューティクス，インコーポレイティド ヒト細胞を若返らせるためのｚｓｃａｎ４の使用方法
JP7633309B2 (ja) 2013-03-15 2025-02-19 エリクサージェン セラピューティクス，インコーポレイティド ヒト細胞を若返らせるためのｚｓｃａｎ４の使用方法
WO2021256346A1 (ja) * 2020-06-16 2021-12-23 ファナック株式会社 ツール設定管理機能を備えた制御装置、制御システム、及びツール

Also Published As

Publication number Publication date
WO2009130330A1 (de) 2009-10-29
EP2281202A1 (de) 2011-02-09
US20110104698A1 (en) 2011-05-05

Similar Documents

Publication Publication Date Title
Atanasova et al. Strategies for measuring airway mucus and mucins
Arron et al. Noninvasive biomarkers that predict treatment benefit from biologic therapies in asthma
EP2466312B1 (en) Phosphoethanolamine as biomarker of depression
Wang et al. S100A6: molecular function and biomarker role
Zhou et al. Elevation of high‐mobility group protein box‐1 in serum correlates with severity of acute intracerebral hemorrhage
US10247738B2 (en) Diagnosing and treating Alzheimers disease
JP2011519030A (ja) ヒトおよび動物における生物学的老化、再生能、発癌リスク、加齢性疾患を発症するリスクおよび慢性疾患の予後を測定するための、ｄｎａ損傷およびテロメア機能不全を測定するためのマーカー
EP3136101A1 (en) Method of testing for pulmonary hypertension
Cai et al. Serum hypoxia-inducible factor 1alpha levels correlate with outcomes after intracerebral hemorrhage
Torres-Perez et al. The FAT expandability (FATe) project: biomarkers to determine the limit of expansion and the complications of obesity
JP2011519030A5 (enExample)
JP2012507268A5 (enExample)
US20150118224A1 (en) Endothelial cells activation biomarkers characterizing antibody mediated rejection and uses thereof
Xu et al. Serum CIAPIN1 is lower in septic patients with cardiac dysfunction
Maximov et al. Copy number of the mitochondrial DNA of leucocytes as an aging marker and risk factors for the development of age-related diseases in humans
JP2013039111A (ja) スプライシングバリアント
CN106093434A (zh) 一种用于肝癌检测的试剂盒
JP2011045334A (ja) 細胞老化関連因子
Kim et al. Reference intervals for plasma amyloid β in korean adults without cognitive impairment
CN114966040B (zh) Hp蛋白在构建辐射后致死性预测模型或制备试剂盒、试剂中的应用
Mohsin Jebur et al. Mast cell, IL-1 Beta and IL-6 for Wound timing and Vitality in Forensic Practice.
Altun et al. Lower Serum Kindlin-2 Levels are Associated with Liver Cirrhosis: A Preliminary Study
Chen et al. Evaluation of CIRBP and ONECUT2 for fatal hypothermia identification—a pilot study
Özdemir et al. The Possible Role of Apelin and Adiponectin in Multiple Sclerosis Pathogenesis
US20210375394A1 (en) Gene to transcriptome association platform for drug target identification

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20120427

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120521

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120608

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20121030

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20121106

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20130201

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20130208

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20130305

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20130312

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130507

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20130611

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20130905

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20130912

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20140225